What is Precision Recruitment?
Precision Recruitment operates at the intersection of biotechnology and patient engagement, specializing in metabolic pre-screening and clinical trial recruitment. With a legacy spanning over 18 years, the company has successfully supported more than 750 clinical trials across diverse therapeutic landscapes. Their core value proposition lies in the integration of Precision AI and automated SMS communication, which streamlines the pre-qualification process for study candidates. By providing a seamless, site-centric support system, Precision Recruitment effectively bridges the gap between clinical trial sponsors, CROs, and research sites, ensuring high-quality participant enrollment and retention throughout the lifecycle of complex medical studies.
How much funding has Precision Recruitment raised?
Precision Recruitment has raised a total of $127K across 1 funding round:
Debt
$127K
Debt (2021): $127K with participation from PPP
Key Investors in Precision Recruitment
PPP
Public-Private Partnership
What's next for Precision Recruitment?
With this late-stage capital injection, Precision Recruitment is well-positioned to accelerate its market penetration and enhance its technological stack. The strategic focus will likely shift toward scaling the deployment of its AI-driven recruitment tools to accommodate larger, multi-center global trials. As the clinical research industry faces increasing pressure to reduce time-to-market for new therapies, Precision Recruitment's ability to optimize patient acquisition will remain a key competitive advantage. Future growth initiatives are expected to prioritize the expansion of their therapeutic footprint and the integration of more sophisticated data analytics to further refine candidate matching, ultimately driving greater efficiency for their partners in the pharmaceutical and biotechnology sectors.
See full Precision Recruitment company page
